Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04696679
Other study ID # 2020-38
Secondary ID 2020-A01631-38
Status Completed
Phase
First received
Last updated
Start date June 19, 2020
Est. completion date December 31, 2020

Study information

Verified date January 2021
Source Assistance Publique Hopitaux De Marseille
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Since March 2020, a new HCoV, SARS-Cov2, originating in China, has been spreading around the world. As of 13 may 2020, almost 4.2 million cases of infections and 292 000 died were reported worldwide (140 000 infection cases and 27 000 died in France). Human coronaviruses (HCoV) usually cause common upper respiratory tract infections in children and sometimes exacerbate lung and asthma diseases. To minimize the risk of contamination of SARS-Cov2 (Covid-19), the French government has put in place directives that modified the daily lives of students, teachers and families. The societal change imposed by the state of health emergency with a confinement and deconfinement period could strongly impact the quality of life of very preterm children with dysexecutive disorders. These children are a population vulnerable to changes, especially during the pivotal period of elementary school. The executive dysfunctions disrupt children's learning and schooling, as well as their social adaptation, compromising their personal development and therefore, their quality of life.


Recruitment information / eligibility

Status Completed
Enrollment 170
Est. completion date December 31, 2020
Est. primary completion date November 30, 2020
Accepts healthy volunteers
Gender All
Age group 7 Years to 9 Years
Eligibility Very preterm children group : - Children at elementary school age 7 to 9 - Children included in the cohort of EPIREMED study, born between 24 and 34 weeks' GA (gestational amenorrhea) and having visuospatial Working Memory impairment defined by a working memory index <85 from the WPPSI IV - Children able to read, write and comprehend; - Children whose parents are not opposed to the participation in the study - Children affiliated to the French social security system Control group : - Children at elementary school age 7 to 9 - Children born at full-term and without dysexecutive disorders - Children from the staff of the Assistance Publique - Hôpitaux de Marseille (AP-HM) / from the staff of the French Mediterranean network (PERINAT-MED) / from the close entourage of EPIREMED children - Children able to read, write and comprehend - Children whose parents are not opposed to the participation in the study - Children affiliated to the French social security system

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Patient Quality of life assessment
Other: Patient questionnaire about quality of life assessment and their determinants during the confinement-deconfinement period of Covid-19 pandemic in France
Control group Quality of life assessment
Other: Patient questionnaire about quality of life assessment and their determinants during the confinement-deconfinement period of Covid-19 pandemic in France relationships with teachers, schoolwork, and self-esteem)

Locations

Country Name City State
France Assistance Publique des Hopitaux de Marseille Marseille

Sponsors (1)

Lead Sponsor Collaborator
Assistance Publique Hopitaux De Marseille

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Assessment of the quality of life using the questionnaire Kidscreen 10 Index The questionnaire Kidscreen 10 Index was developed in several European countries including France. It comprises 10 items from a version of 27 items, which explore the following domains: physical well-being, psychological well-being (positive and negative), autonomy and parents, peers and social support, and school environment 1 day
Primary Assessment of the quality of life using The VSP-A questionnaire (Life and Perceived Health of the Adolescent and the Child) The VSP-A questionnaire (Life and Perceived Health of the Adolescent and the Child) which groups together nine dimensions (vitality, psychological well-being, friendships, recreation, family relationships, physical well-being, relationships with teachers, schoolwork, and self-esteem) 1 day
Secondary Specific data concerning the period of confinement-deconfinement continuation of parental employment and current modalities: face-to-face, teleworking, part-time employment, etc.
possible schooling and current modalities: continued schooling, interruption of schooling, etc.
related ad hoc items to the state of health of the family unit, to medical events that have occurred (including family member(s) with a Covid-19 infection), to a history of hospitalization related to Covid-19 reasons, (reasons, consequences, frequency) between the beginning of the confinement and the moment they complete the questionnaire; as well as ad hoc items of anxiety related to Covid-19
1 day
Secondary Data on children behavioral disorders: assessed by the Goodman questionnaire (Strengths and Difficulties Questionnaire) 1 day
Secondary Data concerning the anxiety symptoms of the parent completing the survey questionnaire: assessed by the Spielberger questionnaire, as a personality trait and as an emotional state linked to the health protocol (State-Trait Anxiety Inventory, STAI) 1 day